Stago, the worldwide leader in the field of Haemostasis is setting the standard of excellence, with cutting-edge technologies, products and customer service.
The United Kingdom is one of the countries where research is the most advanced in the field of coagulation and the demand for new technologies is great. In January 2005, the subsidiary Stago UK was opened.
Stago UK offers a complete system of Haemostasis instrumentation and optimised reagent kits for research as well as for routine analysis. We provide the means and the tools to scientists and clinicians to diagnose and to understand the reasons for Thrombosis or Bleeding disorders.
The Core Values of our organisation remain the foundation of our business:
By implementing these core values since 2005, Stago UK:
Has reached 20 per cent of market share in ten years.
Is working in close collaboration with the scientific community in the UK.
Has a business relationship with all the "Primary Providers" in supplying Pathology Managed Service Contract solutions with Total Laboratory Automation.
Delivers a Business Model meeting the requirements of NHS Hospital Trusts, Private laboratory services and other qualified providers.
Has a team of specialists with more than 20 people covering Sales, Scientific Affairs, Applications and Field Service Engineering.
Is offering a Hotline Service where more than 80 per cent of calls are resolved on line.
The Trinity Biotech coagulation business was acquired by the Stago Group on May 4th 2010 and was renamed as Tcoag.
In the United Kingdom, Tcoag and Stago came together and Stago UK has been operating for both product portfolios, since January 2011.
The synergy between these organisations provided our UK customers with:
Increased Engineering Service coverage
Broader based product offering
Assured delivery with a UK based warehouse
Dedicated Customer service
Enhanced technical and scientific support
Total UK sales coverage